Study of Verinurad in Heart Failure With Preserved Ejection Fraction
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dalane Kitzman, MD
1326 Riverview Road Ext Lexington, NC 27292-1764 USA
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
58 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
CABA, Argentina
- Research Site
CABA, Argentina
- Research Site
CABA, Argentina
- Research Site
Mar del Plata, Argentina
- Research Site
Mar del Plata, Argentina
- Research Site
Rosario, Argentina
- Research Site
Bedford Park, Australia
- Research Site
Chermside, Australia
- Research Site
Geelong, Australia
- Research Site
Milton, Australia
- Research Site
Graz, Austria
- Research Site
Vienna, Austria
- Research Site
Plovdiv, Bulgaria
- Research Site
Sofia, Bulgaria
- Research Site
Sofia, Bulgaria
- Research Site
Québec, Quebec, Canada
- Research Site
Québec, Quebec, Canada
- Research Site
Québec, Quebec, Canada
- Research Site
Québec, Quebec, Canada
- Research Site
Bad Oeynhausen, Germany
- Research Site
Berlin, Germany
- Research Site
Berlin, Germany
- Research Site
Göttingen, Germany
- Research Site
Regensburg, Germany
- Research Site
Würzburg, Germany
- Research Site
Querétaro, Mexico
- Research Site
Bydgoszcz, Poland
- Research Site
Chojnice, Poland
- Research Site
Chrzanów, Poland
- Research Site
Lublin, Poland
- Research Site
Tychy, Poland
- Research Site
Warsaw, Poland
- Research Site
Warsaw, Poland
- Research Site
Warsaw, Poland
- Research Site
Aramil, Russia
- Research Site
Kemerovo, Russia
- Research Site
Novosibirsk, Russia
- Research Site
Saint Petersburg, Russia
- Research Site
Saint Petersburg, Russia
- Research Site
Tomsk, Russia
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 May 2020
- Primary completion
- 29 Apr 2022
- Completion
- 29 Apr 2022
- Last update posted
- 29 Jun 2023
- Registered enrollment
- 159
- Registry id
- NCT04327024
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.